louisiana semaglutide gastric stasis law office legal team in glp-1 attorney glp-1 gastric stasis class action Ozempic Injuries In The News

Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide

Similar to FAERS, VigiBase reports adverse events for consideration, but it does not make conclusions

This means that Tirzepatide may be more effective in weight loss

Strength training while on semaglutide is crucial to preserving your muscle mass

This is rare but could happen if there is a suspicion of medication misuse or an individuals health is under legal review